APSR2026-393

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-043
P62
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220018-46904-AP14-043 Rapid Clinical Improvement Following Empirical EGFR-TKI Therapy in Cytology-Based Diagnosis of Advanced Lung Adenocarcinoma_43419
Format: PDF Only
08. Lung Cancer
10

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Nor Safiqah Sharil * University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia Universiti Sains Islam Malaysia Internal Medical Unit, Faculty of Medicine and Health Science Nilai Malaysia
Boon Hau Ng - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
Nik Nuratiqah Nik Abeed - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
Hsueh Jing Low - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
Nurul Aisyah Abd Rahman - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
Nur Amani Aris - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
Azira Ahmad Kamil - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
Norita Idris - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
Rose Azzlinda Osman - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
Andrea Yu-Lin Ban - University Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz Department of Medicine, Faculty of Medicine Kuala Lumpur Malaysia
 
 
 
 
 
Presenting Author Details
Nor Safiqah
Sharil
n.safiqah@gmail.com
+60172449006
31-40
Malaysia
Case Report
Rapid Clinical Improvement Following Empirical EGFR-TKI Therapy in Cytology-Based Diagnosis of Advanced Lung Adenocarcinoma
Maximum 25 words
Abstract Content
 
 
 
 
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have become a cornerstone in the management of advanced non–small cell lung cancer (NSCLC) with activating EGFR mutations. In patients with high clinical suspicion for EGFR-mutated disease, particularly Asian never-smokers with adenocarcinoma histology, empirical initiation of EGFR-TKI while awaiting molecular results may be considered in selected cases with significant disease burden.
A 74-year-old woman with no smoking history presented with intermittent cough, progressive shortness of breath, and weight loss for three months. On examination, breath sounds were markedly reduced over the left hemithorax. Her oxygen saturation was 86% on room air, requiring supplemental oxygen. Chest radiography demonstrated opacity involving the left mid and lower zones. Thoracic ultrasound confirmed a massive left pleural effusion, and a chest tube was inserted via the Seldinger technique for drainage. Contrast-enhanced CT of the thorax revealed an enhancing lobulated lesion in the left upper lobe measuring 2.7 × 1.7 × 2.7 cm, encasing the left upper lobe bronchus with luminal narrowing, along with a large left pleural effusion. Bronchoscopy showed narrowing of the left upper lobe bronchus with no endobronchial lesion, and bronchoalveolar lavage (BAL) was performed. BAL cytology confirmed lung adenocarcinoma, while pleural fluid cytology was negative for malignant cells. In view of the patient’s clinical profile and advanced disease, empirical gefitinib 250 mg once daily was initiated while awaiting molecular testing. Two weeks later, molecular analysis confirmed an EGFR exon 19 deletion. One month after initiating gefitinib, repeat chest radiography demonstrated significant regression of the left upper zone mass and marked reduction of the pleural effusion, accompanied by clinical improvement.
This case highlights the potential benefit of early empirical EGFR-TKI therapy in carefully selected patients with suspected EGFR-mutated lung adenocarcinoma.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Adenocarcinoma, EGFR-TKI, cytology
maximum 3 keywords and no abbreviations, separated by commas
 
288